# Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer

> **NCT00956228** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 72 (actual)

## Conditions studied

- Prostatic Neoplasm

## Interventions

- **RADIATION:** radioimmuniguided intenstiy modulated radiotherapy

## Key facts

- **NCT ID:** NCT00956228
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956228, "Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00956228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*